Posted in | News | Graphene | Nanobusiness

Cemtrex Announces Plans to Set Up Research Pilot Plant for Graphene Production

Cemtrex Inc., a world leading industrial and manufacturing solutions company, announced today that it will set up a research pilot plant for the production of Graphene while simultaneously sequestering carbon dioxide from flue gases at its Farmingdale facility. The Company expects the research pilot plant to commence within six months.

The Company had already been deeply involved in UNFCCC (United Nations Framework Convention on Climate Change) Clean Development Mechanism project work in past years, when it developed its VAMOX technology for destruction of low level methane from coal mines to generate carbon credits. Now with renewed global interest in the reduction of greenhouse gases, the Company plans to restart its research activities to strengthen its foothold within this sector. Initially, in the basic research the Company plans to evaluate certain new concepts to generate graphene nanoparticles while capturing Sulfur dioxide, nitrogen oxides and carbon dioxide from flue gases.

Cemtrex's Chairman and CEO, Saagar Govil (@SaagarGovil) , commented, "In the coming decade we anticipate the greenhouse gas reduction market to grow substantially and hence want to strengthen our position within this space by developing additional cutting edge technologies." "We want to have a stake in the production of the graphene nanoparticles and are looking at ways to accomplish this, using sustainable and ecofriendly methods," continued Mr. Govil.

Source: http://www.cemtrex.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.